Setmelanotide
Setmelanotide for the Treatment of Leptin Receptor (LEPR) Deficiency Obesity
Rhythm · Phase 3 · Completed · Enrollment 15
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Setmelanotide | Obesity or overweight | n/r | 12 | n/r | -12.34% at week 52 |